Nutrien Ltd. (NTR.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Nutrien Ltd. (NTR.TO)

93.46

+1.08 (1.17%)

as of Aug 11, 2026, 6:33:16 pm Market Open.

776 watching

Investor Insights

Aug 11, 2026, 12:00 am

This summary was created by AI, based on 23 opinions in the last 12 months.

Nutrien Ltd. (NTR) has been showing signs of resilience amidst geopolitical disruptions, particularly from conflicts affecting fertilizer supply chains, like the wars in Ukraine and the Middle East. Experts highlight a stabilizing demand for fertilizers, driven by a growing population and an emphasis on agricultural needs. The company is perceived favorably due to its solid dividend yield, with most professionals indicating that this yield is safe and has been consistently growing over the years. Despite short-term uncertainties and market volatility, many analysts see potential for recovery as they expect the stock to benefit from improved farmer balance sheets and potentially lower input costs. The general sentiment suggests a balanced outlook, encouraging long-term investment strategy while being cautious of short-term fluctuations.

Consensus

Buy

Valuation

Fair Value

Similar

CF Industries, CF

TOP PICK

Capable CEO will be found. Assets will be there regardless. Pullback is buyable. Absolute bonanza of positives: high cash crop prices, flooding, sanctions elsewhere. They'll make a boatload of money this year, meaning dividend increases and buybacks. Yield is 2.70%. (Analysts’ price target is $102.76)

BUY ON WEAKNESS

Recommends Getting tailwinds on higher fertilizer pricing. Also higher commodity prices help. Retail business is biggest strength. Demand for products will be remain strong.

HOLD

Prices moving significantly higher, raised guidance twice in last year. Inventories low, demand high. Retail business remains strong. Outlook for 2022 remains strong, blue skies. Already baked in, so be cautious about buying. A hold.

BUY

Commodity prices have been very strong. She wonders if we are at a point where we see demand destruction. Farmer incomes are strong. There has been some US Administration tension over Belarus that may keep the potash market tight. They raised guidance and beat earnings, yet the stock sold off. She still owns it in their Canadian equity portfolio and continues to like it here.

BUY

Has been following this story closely. Nitrogen and potash prices are running up. A solid demand environment for Nutrien which should support their valuation. Last quarter was great. Would continue to hold it.

BUY

Sensational quarter. Operating profit and sales above already high expectations. Really strong cashflow. Outlook for Q4 is even better. Real question is when do we get to the top of the cycle? Quality asset, but don't forget it's still a commodity. Not there yet. Will make a lot of money in 2022, a lot of which will come back to shareholders. Looking for triple digit handle before the cycle is done. Good upside from here.

SELL ON STRENGTH

Last quarter, they massively lifted guidance. Was expecting $4.5B up to $6B. China restricting exports also raised prices. 63% EPS growth and the stock is still not expensive and has a decent dividend. It is cyclical however. Take some money off if it is a large holding.

DON'T BUY

On the balance sheet, 60% is nothing but goodwill, and this concerns him. Cost pressures such as natural gas put pressure on the stock. Global warming suggests farmers want fertilizer to increase production to offset effects of the weather. In the next bear market, balance sheets and the quality of book values will make the difference between survival and wipeout.

PAST TOP PICK

(A Top Pick Feb 10/21, Up 27%) A movement in fertilizer prices due to nitrogen plant shut downs in Europe and there are logistics issues due to hurricane Ida. Government sanctions on Belarus has kept prices up for fertilizers. If higher price action continues, should rebalance.

BUY

Steady cashflow, strong balance sheet, management adapts to fast-changing ag market. Outperformed TSX since last summer. Long-term, helps arable land efficiencies. Opportunities in China and India will lead to higher demand. A name to own. Makes sense for growth investors.

BUY ON WEAKNESS

He has liked it for a while now He took a little bit off the table recently but still has a pretty decent position. He is looking at it as a position to pick up more of a position on weakness.

PAST TOP PICK

(A Top Pick Jul 24/20, Up 86%) Was a name they purchased in 2016 before the merger. You get mining and extraction of potash but also the full cycle to retail. People will continue to eat and countries are thinking about food security. A name that you will see more volatility but it is normal and important to have some agriculture exposure.

BUY

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The company will report earnings today. Currently trading at 15x earnings. Contract prices have risen but it depends whether farmers are still comfortable at higher prices. Has beaten estimates in the past four quarters. Unlock Premium - Try 5i Free

BUY

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The company has benefitted from the merger between Potash and Agrium and there has been synergy. More cyclical than expected. However the market share, valuation, growth potential and market cap makes it the best bet in the sector. Strong earnings growth is expected and results were strong last quarter. Unlock Premium - Try 5i Free

HOLD

One of the biggest fertilizer producer in the world. Long term agriculture should see decent growth. There is a lot of potash. Has done some mergers in recent years. Prices have finally rallied from the bottom. The stock has gone from below $30s to up to mid $70s. Likes the area but would be cautious at these levels. There might be better opportunities.

Showing 196 to 210 of 389 entries

Most Recent Experts

Eric Nuttall

Ninepoint Partners

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Jim Lebenthal

Cerity Partners

Karen Firestone, CEO, Aureus Asset Management

Aureus Asset Management

Anastasia Amoroso, Chief investment strategist, iCapital

iCapital

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Nutrien Ltd. (NTR.TO)